In a major clinical milestone, Prof. Lu Jian’s urology team at Beijing Haidian Hospital successfully performed a total robot-assisted radical cystectomy using the SHURUI® single-port system. The 75-year-old patient, diagnosed with recurrent muscle-invasive bladder cancer and ureteral involvement, underwent complete bladder and prostate removal with intracorporeal urinary reconstruction—all via a 3 cm umbilical incision.
Guided by a high-definition 3D camera and powered by snake-like instruments, the procedure achieved precise dissection, minimal bleeding, and zero transfusion. The entire surgical workflow was completed smoothly on the SHURUI® platform.
This case highlights the SHURUI® surgical system’s capabilities in tackling complex urologic oncology cases with minimal trauma and faster recovery. As single-port robotic technology advances, Surgerii Robotics continues to push the boundaries of ultra-minimally invasive surgery—delivering safer, more precise, and patient-centered solutions in bladder cancer treatment and beyond.
Important Notes
The SHURUI Single-port Endoscopic Surgical System (SR-ENS-600), developed and produced by Beijing Surgerii Robotics Company Limited, has obtained the CE marking for urologic laparoscopic surgical procedures, gynecologic laparoscopic surgical procedures, general laparoscopic surgical procedures, and thoracoscopic surgical procedures. It is intended for use by trained surgeons in an operating room environment in accordance with the representative, specific procedures set forth in the User Manual.
Safety and Performance Information
Beijing Surgerii Robotics Co., Ltd. owns Surgerii®, SHURUI®, and other trademarks and may not be used without permission.
